Recent News 39 : Phage Therapy Market Gains Momentum in Food Safety and Human Health

-
Phage Therapy Market Gains Momentum in Food Safety and Human Health


Global Phage Therapy Market is expected to grow at an 20.50% CAGR during the forecast period for 2025-2034.

Bacteriophages, commonly referred to as phage therapy, are viruses that selectively infect specific bacterial strains without affecting beneficial microbiota within the human body. Due to their composition-primarily nucleic acids and proteins-phages are inherently non-toxic and exhibit minimal side effects. They may be administered via various routes, including oral intake, topical application, or surgical intervention. Their adaptability in formulation enables integration with conventional antibiotics, offering synergistic therapeutic benefits.

The growth of the global phage therapy market is driven by several key factors, including increasing applications in the food and beverage industry, the ability of phages to target specific pathogenic bacteria, extensive research and development initiatives, and the rising incidence of antimicrobial resistance (AMR). Additionally, the prevalence of foodborne illnesses and the escalating threat of antibiotic resistance-largely attributed to the overuse and misuse of antibiotics-further underscores the urgency of developing alternative treatments such as bacteriophages. Phage therapy also presents a viable option for patients with allergies to traditional antibiotics, as allergic reactions to phages are rare.

Despite its promise, the market faces notable challenges. These include a shortage of skilled professionals and technicians specializing in phage research and therapy, as well as the high failure rates associated with drug development and commercialization. However, the emergence of advanced bacteriophage platforms and a growing patient base-particularly in developing economies-are creating substantial growth opportunities within the market.

Comments

Post a Comment

Popular posts from this blog

History Part 12 : Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s)

-
Image
Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s) The period following World War II marked a decisive turning point in the trajectory of phage therapy in Western medicine. Despite the promising results bacteriophages had demonstrated prior to the war as potential antibacterial agents, the decades after 1945 saw a dramatic decline in interest, funding, and scientific engagement with phage therapy in the United States and much of Western Europe. This marginalization can be attributed to a confluence of scientific, sociopolitical, and economic factors that reshaped the landscape of infectious disease treatment and research. Artistic View One of the key contributors to this decline was the overwhelming optimism surrounding the newly discovered class of antibiotics. The post-war pharmaceutical revolution brought forward a series of broad-spectrum antibiotics such as streptomycin, tetracycline, and chloramphenicol, which were viewed as miracle drugs capable o...
Read more

The Phage Therapy in the spotlight !

-
Image
Bacteriophages: Ancient Predators and the Next Frontier in Medicine In the animated documentary The Deadliest Being on Planet Earth , the Kurzgesagt team delves into the world of bacteriophages—viruses that prey exclusively on bacteria. With vibrant visuals and precise narration, the video introduces viewers to an invisible ecosystem where microscopic hunters orchestrate life-and-death dramas that shape the biosphere. These entities, though virtually unknown to the general public, may soon become central to the future of medicine. At the heart of the video lies a paradox: bacteriophages (or "phages") are among the most abundant biological entities on Earth—outnumbering all other organisms combined—yet their therapeutic potential has been largely sidelined in the antibiotic era. The video outlines the historical trajectory of phage research, spotlighting Félix d’Hérelle’s early 20th-century work and the rise of phage therapy, only to show how it was later eclipsed by the dis...
Read more

Paper 3 : Phage Therapy May Treat Drug Resistance in Patients With Cystic Fibrosis, Study Finds

-
Image
Phage Therapy May Treat Drug Resistance in Patients With Cystic Fibrosis, Study Finds June 13, 2025 "Yale's university researchers find a new approach to combatting antimicrobial resistance. Antimicrobial resistance, in which germs like bacteria and fungi no longer respond to medicines, is a rising global threat. When antibiotics and other drugs become ineffective, infections can become difficult or impossible to treat, leading to an increase in the spread and severity of disease. In a new study, published in Nature Medicine , a team of researchers at the Center for Phage Biology and Therapy at Yale discovered a novel approach that may revolutionize the fight against antimicrobial resistance. Jon Koff, MD, with a patient Credit: Robert A. Lisak For the study, the research team investigated the use of phage therapy—the use of viruses, or phages, to target and kill bacteria—to help patients with cystic fibrosis, a disease in which antimicrobial resistance is a significant issue....
Read more